SCHEMBL7550282

SCHEMBL7550282

CC(Nc1nccc(-n2cnc3ccccc32)n1)C1CN(Cc2ccccc2)CCN1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7990610 0.85 LCK (0.74) LCK
SCHEMBL7587843 0.82 LCK (1.00) LCK
SCHEMBL7541829 0.79 LCK (0.67) LCK
SCHEMBL7542352 0.78 LCK (0.68) LCK
SCHEMBL7874530 0.76 LCK (1.00) LCK
SCHEMBL7495391 0.76 LCK (1.00) LCK
SCHEMBL7873119 0.76 LCK (1.00) LCK
SCHEMBL7973150 0.75 LCK (0.78) LCK
SCHEMBL7551486 0.75 LCK (1.00) LCK
SCHEMBL7972879 0.75 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 US disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed